Journal
PHARMACEUTICS
Volume 13, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13030328
Keywords
anti-inflammatory activity; etofenamate; ibuprofen; solid lipid nanoparticles (SLN); hydrogels; dermal delivery
Categories
Funding
- Portuguese Foundation for Science and Technology (FCT) [SFRH/BDE/3379/5/2009, UID/DTP/04138/2019, UIDB/04138/2020]
- [CEECIND/03143/2017]
- [CEECINST/00145/2018]
Ask authors/readers for more resources
The study investigates the use of SLNs to enhance skin permeation and in vivo activity of two NSAIDs. Results show that SLN formulations can achieve similar effects to commercial formulations at lower doses, with no adverse effects on the skin.
Innovative formulations, including solid lipid nanoparticles (SLNs), have been sought to improve skin permeation of non-steroidal anti-inflammatory drugs (NSAIDs). The present study explores the use of SLNs, prepared using a fusion-emulsification method, to increase skin permeation and in vivo activity of two relevant NSAIDs: A liquid molecule (etofenamate) and a solid one (ibuprofen), formulated in a 2% hydroxypropyl methylcellulose gel through the gelation of SLN suspensions. Compritol(R) 888 ATO and Tween(R) 80 were used as a solid lipid and a surfactant, respectively. All production steps were up scalable, resulting in SLNs with high encapsulation efficiency (>90%), a mean particle size of <250 nm, a polydispersity index <0.2, and that were stable for 12 months. In vitro permeation, using human skin in Franz diffusion cells, showed increased permeation and similar cell viability in Df and HaCaT cell lines for SLN formulations when compared to commercial formulations of etofenamate (Reumon(R) Gel 5%) and ibuprofen (Ozonol(R) 5%). In vivo activity in the rat paw edema inflammation model showed that SLN hydrogels containing lower doses of etofenamate (8.3 times lower) and ibuprofen (16.6 times lower) produced similar effects compared to the commercial formulations, while decreasing edema and inflammatory cell infiltration, and causing no histological changes in the epidermis. These studies demonstrate that encapsulation in SLNs associated to a suitable hydrogel is a promising technological approach to NSAIDs dermal application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available